GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.609
-0.020 (-3.24%)
At close: Dec 5, 2025, 4:00 PM EST
0.603
-0.006 (-1.05%)
After-hours: Dec 5, 2025, 7:03 PM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.48 million as of December 5, 2025. Its market cap has decreased by -1.79% in one year.
Market Cap
6.48M
Enterprise Value
3.95M
1-Year Change
-1.79%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.48M, a decrease of -92.21%. That is a compound annual growth rate of -28.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 6.70M | -1.47% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |